Journal profile · Infectious Diseases
MEDECINE ET MALADIES INFECTIEUSES
ISSN 0399-077X · eISSN 1769-6690 · Elsevier Masson · FRANCE · Monthly · Founded 1971
MEDECINE ET MALADIES INFECTIEUSES: impact factor 3.65; subscription journal; APC about USD 1,713; review 6–12 weeks (community reports); community-reported acceptance: easy (Elsevier website: 46%); 0 articles in 2025.
Scope
Aims, scope and focus
MEDECINE ET MALADIES INFECTIEUSES is published by Elsevier Masson. By OpenAlex counts of its recent articles, its largest topics are Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria and Bacterial Infections and Vaccines, together about 24.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
L'organe d'expression de la Société de Pathologie Infectieuse de Langue Française (SPILF). Médecine et Maladies Infectieuses is the official publication of the Société de Pathologie Infectieuse de Langue Française (SPILF). Médecine et Maladies Infectieuses is indexed in the major databases: Medline, Web of Science/Clarivate and Scopus. The journal publishes scientific /research articles, general reviews, short communications and letters, in both English and French. The journal welcomes submissions on the various aspects of infectious pathologies and pathogenic agents. Médecine et Maladies Infectieuses focuses on clinical therapeutics, nosocomial infections, biology, prevention, as well as epidemiology and therapeutics.
Source: LetPub
Research area (LetPub): Infectious Diseases
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Use and ResistanceImmunology and Microbiology10.2%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology7.5%
- Bacterial Infections and VaccinesImmunology and Microbiology7.2%
- Pneumonia and Respiratory InfectionsMedicine5.6%
- Infectious Diseases and TuberculosisMedicine5.5%
- HIV/AIDS Research and InterventionsMedicine5.2%
- Infection Control in HealthcareMedicine5.1%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Infectious Diseases | Q3 | 212/283 | 25th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.65LetPub ·
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.27LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 30LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 1,017OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 4.21%LetPub ·
Articles by year OpenAlex count · 11,782 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 1,142 |
| 2025 | 0 | 0 | 1,809 |
| 2024 | 0 | 0 | 2,193 |
| 2023 | 0 | 0 | 2,660 |
| 2022 | 0 | 0 | 2,833 |
| 2021 | 0 | 0 | 3,165 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- 46%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 1,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- FRANCE
- Frequency
- Monthly
- Founded
- 1971
- ISSN
- 0399-077X
- Electronic ISSN
- 1769-6690
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about MEDECINE ET MALADIES INFECTIEUSES
What is the impact factor of MEDECINE ET MALADIES INFECTIEUSES?
The latest impact factor listed by LetPub is 3.65; CiteScore 1.1, h-index 64.
How long does peer review take at MEDECINE ET MALADIES INFECTIEUSES?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy (Elsevier website: 46%)”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is MEDECINE ET MALADIES INFECTIEUSES open access, and what is the APC?
MEDECINE ET MALADIES INFECTIEUSES is a subscription journal. APC about USD 1,713.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .